Answers are grounded in this paper and cite their sources.
This systematic review suggests that BZD prescribing to older adults is significantly in excess of what the available evidence suggests is appropriate. Future trials should focus on efforts to reduce both acute and chronic BZD use among older adults while improving access to effective non-pharmacologic treatment alternatives.
No takes yet. Share an insight, caveat, or question.
Gerlach et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: